Understanding and learning from the diversification of cannabis supply laws
- PMID: 27891693
- PMCID: PMC5446799
- DOI: 10.1111/add.13623
Understanding and learning from the diversification of cannabis supply laws
Abstract
Background and aims: Prohibitions on producing, distributing and selling cannabis are loosening in various jurisdictions around the world. This paper describes the diversification of cannabis supply laws and discusses the challenges to and opportunities for learning from these changes.
Methods: We document changes in cannabis supply laws that de jure legalized cannabis production for medical and/or non-medical purposes (excluding industrial hemp) in Australasia, Europe, North America and South America. We also highlight challenges to evaluating these legal changes based on our experiences studying cannabis laws and policies in the United States.
Findings: As of August 2016, two countries have passed laws to legalize large-scale cannabis production for non-medical purposes at the national (Uruguay) or subnational level (four US states). At least nine other countries legally allow (or will soon allow) cannabis to be supplied for medicinal purposes. Most of the changes in cannabis supply laws have occurred since 2010. The data available in most countries are inadequate for rigorously evaluating the changes in cannabis supply laws.
Conclusion: The evidence base for assessing changes in cannabis supply laws remains weak. Efforts should focus upon collecting information about quantities consumed and market transactions as well as validating self-report surveys.
Keywords: Cannabis; legalization; marijuana; policy analysis; program evaluation; surveys; validating self-reported data.
© 2016 Society for the Study of Addiction.
Figures
Comment in
-
European observations on cannabis legalization.Addiction. 2017 Jul;112(7):1136-1137. doi: 10.1111/add.13740. Epub 2017 Feb 2. Addiction. 2017. PMID: 28155251 No abstract available.
-
Data on cannabis use now that legalization is gaining momentum.Addiction. 2017 Jul;112(7):1138-1140. doi: 10.1111/add.13769. Epub 2017 Feb 13. Addiction. 2017. PMID: 28194818 No abstract available.
-
On sentinel samples, sales data and potency.Addiction. 2017 Jul;112(7):1137-1138. doi: 10.1111/add.13756. Epub 2017 Feb 13. Addiction. 2017. PMID: 28194819 No abstract available.
-
Building the data infrastructure to evaluate cannabis legalization.Addiction. 2017 Jul;112(7):1140-1141. doi: 10.1111/add.13824. Epub 2017 May 5. Addiction. 2017. PMID: 28477353 No abstract available.
References
-
- MacCoun RJ, Reuter P. Drug War Heresies: Learning From Other Vices, Times, and Places. New York: Cambridge University Press; 2001.
-
- MacCoun RJ, Reuter P. Assessing drug prohibition and its alternatives: a guide for agnostics. Ann Rev Law Soc Sci. 2011;7:61–78.
-
- Pacula R, MacCoun R, Reuter P, Chriqui J, Kilmer B, Harris K, et al. What does it mean to decriminalize marijuana? A cross-national empirical examination. Adv Health Econ Health Serv Res. 2005;16:347–69. - PubMed
-
- Room R, Fischer B, Hall W, Lenton S, Reuter P. Cannabis Policy: Moving Beyond the Stalemate. Oxford: Oxford University Press; 2010.
-
- MacCoun RJ, Saiger AJ, Kahan JP, Reuter P. Drug Policies and Problems: The Promise and Pitfalls of Cross-National Comparison. Santa Monica, CA: RAND; 1993.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials